- Home
- ODV vs VIR Comparison
ODV vs VIR Comparison
Compare ODV & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ODV
- VIR
- Stock Information
- Founded
- ODV 2005
- VIR 2016
- Country
- ODV Canada
- VIR United States
- Employees
- ODV N/A
- VIR N/A
- Industry
- ODV Precious Metals
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- ODV Basic Materials
- VIR Health Care
- Exchange
- ODV Nasdaq
- VIR Nasdaq
- Market Cap
- ODV 866.1M
- VIR 706.4M
- IPO Year
- ODV N/A
- VIR 2019
- Fundamental
- Price
- ODV $3.55
- VIR $5.63
- Analyst Decision
- ODV
- VIR Strong Buy
- Analyst Count
- ODV 0
- VIR 11
- Target Price
- ODV N/A
- VIR $25.73
- AVG Volume (30 Days)
- ODV 1.4M
- VIR 1.1M
- Earning Date
- ODV 11-11-2025
- VIR 10-30-2025
- Dividend Yield
- ODV N/A
- VIR N/A
- EPS Growth
- ODV N/A
- VIR N/A
- EPS
- ODV N/A
- VIR N/A
- Revenue
- ODV $5,147,156.00
- VIR $19,000,000.00
- Revenue This Year
- ODV $317.30
- VIR N/A
- Revenue Next Year
- ODV $40.73
- VIR $15.25
- P/E Ratio
- ODV N/A
- VIR N/A
- Revenue Growth
- ODV N/A
- VIR N/A
- 52 Week Low
- ODV $1.16
- VIR $4.16
- 52 Week High
- ODV $3.73
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- ODV 66.91
- VIR 59.22
- Support Level
- ODV $3.19
- VIR $5.36
- Resistance Level
- ODV $3.53
- VIR $6.00
- Average True Range (ATR)
- ODV 0.19
- VIR 0.28
- MACD
- ODV 0.02
- VIR 0.03
- Stochastic Oscillator
- ODV 79.24
- VIR 65.62
About ODV Osisko Development Corp.
Osisko Development Corp is a mineral exploration and development company engaged in the acquisition, exploration, and development of precious metals resource properties in North America. The company is focused on exploring and developing its mining assets, including the Cariboo Gold Project in British Columbia, the San Antonio gold project in Mexico, and the Trixie test mine in the USA. The Company manages its business through the exploration, evaluation, and development activities of its projects.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.